Protagenic Therapeutics, Inc.new (PTIXW)
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Founded
1994
Number of Employees
3
Website
http://www.protagenic.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)